SCHEMBL2828284

SCHEMBL2828284

Cc1onc(-c2ccccc2)c1C(=O)c1cc2c(ccc3ccccc32)o1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.54
HTT P42858 4/20 0.54
MAPT P10636 3/20 0.54
HPGD P15428 3/20 0.54
TSHR P16473 3/20 0.54
HSD17B10 Q99714 2/20 0.54
GLA P06280 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
GAA P10253 3/20 0.53
KMT2A Q03164 3/20 0.53
MEN1 O00255 1/20 0.53
ALDH1A1 P00352 5/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
BACE1 P56817 2/20 0.50
POLB P06746 3/20 0.45
LMNA P02545 2/20 0.45
CYP1A2 P05177 1/20 0.45
CTDSP1 Q9GZU7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4593198 0.85 KMT2A (0.59) HTTMAPTHPGDTSHRL3MBTL1
SCHEMBL2827855 0.81 KMT2A (0.54) KDM4EHTTMAPTHPGDTSHR
SCHEMBL2830198 0.81 KMT2A (0.51) KDM4EHTTHPGDTSHRHSD17B10
SCHEMBL2830358 0.80 KMT2A (0.53) KDM4EHTTMAPTTSHRTDP1
SCHEMBL4592280 0.80 KMT2A (0.53) KDM4EHTTHPGDTSHRTDP1
SCHEMBL2825483 0.79 TSHR (0.56) KDM4EHTTMAPTTSHRGAA
SCHEMBL2827281 0.78 TSHR (0.55) KDM4EHTTTSHRGAAKMT2A
SCHEMBL2825512 0.77 KMT2A (0.52) KDM4EHTTMAPTHPGDTSHR
SCHEMBL2825529 0.77 L3MBTL1 (0.48) KDM4EHTTMAPTHPGDTSHR
SCHEMBL2827017 0.77 TSHR (0.56) KDM4EHTTHPGDTSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1948648-B1 3-ARYL-ISOXAZOLE-4-CARBONYL-BENZOFURANE DERIVATIVES HOFFMANN LA ROCHE (CH) 2010-05-05 EP disclosed
EP-1948648-A2 3-ARYL-ISOXAZOLE-4-CARBONYL-BENZOFURAN DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-07-30 EP disclosed
US-7388025-B2 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives HOFFMAN-LA ROCHE INC. (US) 2008-06-17 US disclosed
WO-2007054444-A2 3-ARYL-ISOXAZOLE-4-CARBONYL-BENZOFURAN DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-05-18 WO disclosed
US-20070105922-A1 3-aryl-isoxazole-4-carbonyl-indole derivatives F. HOFFMANN-LA ROCHE AG (CH) 2007-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105922-A1 3-aryl-isoxazole-4-carbonyl-indole derivatives GABRA5, GABRA4, GABRA3 KDM4E 1096/4885HTT 1743/4885MAPT 237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.